[1]JournalofMedicinalChemistry,1981,vol.24,p.481-490
[2]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.3535-3539
[3]OrganicLetters,2018,vol.20,p.1832-1836
[1]Patent:EP3170822,2017,A1.Locationinpatent:Paragraph0558-0560
137420-52-1
14062-29-4
2856-79-3
5445-25-0
3381-74-6
41204-08-4
42288-55-1 | [3-(Aminomethyl)phenyl]acetic acid hydrochloride | AA00I849 | MFCD25963377
438049-35-5 | 1-N-Boc-3-ethylpiperazine | AA00I89T | MFCD07367735
455-67-4 | 3'-Fluoropropiophenone | AA00I8FW | MFCD00061245
475278-66-1 | N-(5-Fluoro-2-nitrophenyl)methanesulfonamide | AA00I8L7 | MFCD25630431
486460-20-2 | 3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine | AA00I8Q2 | MFCD09029664
501902-75-6 | 3-(2,4,5-Trimethylphenyl)-1h-pyrazol-5-amine | AA00I8W9 | MFCD02664128
511284-39-2 | 3-{2-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]acetamido}benzoic acid | AA00I92Q | MFCD03771461
5208-93-5 | 3-Methyl-1-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-1,4-dien-3-ol | AA00I98K | MFCD09751288
52853-74-4 | 3-(3-Chlorophenyl)-1,2,4-triazole | AA00I9D9 | MFCD24394207
537037-56-2 | 1-(3,4-Difluorophenyl)biguanide, HCl | AA00I9I6 | MFCD03094449
1955547-39-3
1207027-24-4
1105191-52-3